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Association of Cortisol and the Metabolic Syndrome in Korean 
Men and Women
Obesity and the metabolic syndrome are closely related and have become increasingly 
prevalent in Korea. The cardiovascular disease (CVD) risk factors comprising the metabolic 
syndrome have previously been associated with increased hypothalamic-pituitary-adrenal 
axis (HPAA) activity, but the associations have not been extensively examined in non-
Caucasian populations. The aim of the present study was to investigate the relationships 
between cortisol, adiposity and the metabolic syndrome in a Korean population. A total of 
1,881 adults participated in the study between January 2001 and February 2008. 
Sociodemographic data were assessed by questionnaires. Body composition, clinic blood 
pressures as well as metabolic variables including glucose, insulin, and lipid profile were 
assessed and analyzed in relation to cortisol levels. Mean age of the participants was 58.7 
± 10.8 yr. Higher levels of cortisol was associated with elevated blood pressure, fasting 
glucose and total cholesterol in men, and between cortisol and systolic blood pressure, 
fasting glucose and total cholesterol in women. There was an increased risk for the 
metabolic syndrome associated with higher cortisol levels in both men (P < 0.001) and 
women (P = 0.040) adjusting for age and body mass index. Higher cortisol levels are 
associated with several CVD risk factors and the metabolic syndrome, independent of 
overall of adiposity level, in Korean men and women. 
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INTRODUCTION 
Glucocorticoids, mediated by activation of the hypothalamic-
pituitary-adrenal (HPA) axis, have an impact on metabolic re-
sponses, insulin-resistance and lipolysis (1). Glucocorticoids 
directly impair insulin sensitivity in adipocytes (2) and promote 
free fatty acid release from mature adipocytes through hormone 
sensitive lipase (HSL)-mediated lipolysis (3). These events are 
mediated by Glucocorticoid Receptors (GR). The density of these 
receptors is higher in intraabdominal visceral than other fat de-
pots, and the activity of cortisol will be accentuated in this par-
ticular adipose tissue (4). It is now apparent that tissue-specific 
changes in cortisol metabolism is primarily increased intracellu-
lar glucocorticoid reactivation, catalysed by the enzyme 11-hy-
droxysteroid dehydrogenase type (HSD)-1 in adipose tissue (5).  
  Abdominal obesity promotes insulin resistance and is consid-
ered a main part of the metabolic syndrome (6, 7). Although cor-
tisol has been implicated as a pathophysiological contributor to 
idiopathic obesity, circulating cortisol has not consistently been 
shown to be elevated in obese as compared to normal weight 
individuals (8). A recent study using both cross-sectional and lon-
gitudinal analysis to determine the associations between body 
composition and serum cortisol concentrations in men showed 
that weight change drives the changes in cortisol concentrations, 
rather than vice versa (9). 
  In addition, studies have shown that cortisol may add to the 
effect of adiposity on metabolic risk. Ward et al. (10) reported 
that higher cortisol concentrations increased the risk for cardio-
vascular disease (CVD) risk factors in a South Asian cohort study, 
above what could be explained by the effect of adiposity alone. 
In that study, associations between cortisol concentration and 
CVD risk factors were also stronger than what has previously 
been shown in Caucasian populations, despite similar cortisol 
levels. Asian populations have been shown to have a different 
fat distribution pattern than Western populations and seem to 
be more prone to central obesity and metabolic dysregulation 
even at lower body mass index (BMI) levels (11, 12). However, 
increased prevalence of overweight and obesity does not fully 
explain the higher prevalence of the metabolic syndrome in 
Asian populations (12-14), and the role of glucocorticoids has 
not been investigated in Korean individuals. We hypothesized 
that cortisol would be positively and independently associated 
with increased CVD risk, assessed as components of the meta-
bolic syndrome.Park SB, et al.  •  Cortisol and Metabolic Syndrome in Koreans
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MATERIALS AND METHODS
Study population  
We enrolled 2,219 Korean individuals > 20 yr old who had un-
dertaken medical evaluation at Ajou University Hospital be-
tween January 2001 and February 2008. Participants were ex-
cluded if they were taking steroid medication or did not provide 
information about smoking status, alcohol consumption, or 
physical activity (n = 338) leaving a sample of 1,881 participants 
(56.1% female).
 
Data collection 
Sociodemographic characteristics, smoking status, alcohol hab-
its, and activity level were assessed by questionnaire. Socioeco-
nomic status (SES) meant financial affordability; and exercise 
was defined by moderate or severe vs none or sedentary. Height 
and weight were measured using bioelectrical impedance anal-
ysis (Inbody 3.0, Biospace, Seoul, Korea) following overnight fast. 
BMI was calculated as weight divided by height squared (kg/m
2) 
(15). Waist circumference was measured between the lower rib 
and iliac crest by a trained nurse. Blood pressure was measured 
by a semi-automated blood pressure monitor (TM-2650A, PMS 
Instruments, Tokyo, Japan) after a rest of at least 15 min.
  Venous blood was drawn following an 8-hr overnight fast 
and 24-hr abstinence from vigorous activity. Fasting glucose, 
total cholesterol and triglyceride level were assessed with an 
enzymatic colorimetric method (TBA-200FR, Toshiba, Tokyo, 
Japan); Serum insulin was determined with an immunoradio-
metric assay kit (Dnabot, Tokyo, Japan) and cortisol with a RIA 
method (Diagnostic Products Cooperation, Los Angeles, CA, 
USA). We calculated the insulin resistance index using the         
homeostasis model assessment (HOMA) of insulin resistance 
(16). 
Statistical analysis
We followed the NCEP-ATP III Asian guideline components to 
define metabolic syndrome, comprised of central obesity (waist 
circumference ≥ 90 cm for men and ≥ 85 cm for women), blood 
pressure ≥ 130/80 mmHg, triglyceride ≥ 150 mg/dL, fasting glu-
cose ≥ 110 mg/dL, and high-density lipoprotein cholesterol (men 
< 40 mg/dL and women < 50 mg/dL). In line with the guidelines, 
subjects who met three or more of the criteria mentioned above 
were defined as having the metabolic syndrome (17, 18).
  Chi-square test and Student’s t-test were used to calculate the 
difference in mean values of general characteristics and labora-
tory tests between men and women. Regression analysis was 
conducted to assess the association between cortisol and CVD 
risk factors while controlling for age and BMI. Further regression 
analysis was assessed to evaluate the relation of cortisol concen-
tration to the separate CVD risk variables while simultaneously 
controlling for confounders such as SES, smoking status, alco-
hol intake and exercise. Finally, logistic regression analysis was 
used to evaluate the association of cortisol levels to the metabol-
ic syndrome, controlling for age and BMI. A P < 0.05 was used 
as cutoff for significance. SPSS in version 12.0 was used for all 
statistical analysis.
 
Ethics statement  
The institutional review board of Ajou University approved the 
study (AJIRB-MED-MDB-10-031). In the approval by the board, 
informed consent from the survey participants was waived.  
RESULTS
Demographic characteristics  
A total of 1,881 individuals were assessed, 826 men (43.9%) and 
1,055 women (56.1%) (Table 1). The mean age of the subjects 
was 58.7 ± 10.8 yr and the mean BMI for all subjects was 24.3 ± 
3.3 kg/m
2. The mean cortisol level for all subjects was 12.7 ± 4.8 
μg/dL. Mean levels (± SD) of study variables are presented by 
gender in Table 1. There were gender differences on several de-
mographic and clinical variables, including age, waist circum-
ference (WC), BMI, cortisol levels, HDL cholesterol, total cho-
lesterol, and systolic blood pressure). In addition, men had high-
er alcohol consumption and were more often smokers in com-
parison to women. Almost 32% of the women and 21% of the 
men met criteria for the metabolic syndrome.
Table 1. General characteristics of the study subjects 
Parameters Male (n = 826) Female (n = 1,055) P values
Age (yr)   57.9 ± 11.8   59.4 ± 10.0 0.004
WC (cm) 84.8 ± 9.0 83.6 ± 8.4 0.003
BMI (kg/m
2) 23.8 ± 3.2 24.7 ± 3.3 < 0.001
SES (%)
   Low
   Middle
   High
 
20.6
72.9
  5.3
 
22.3
72.6
  3.4
0.215
Current smoking (%) 36.4   4.2 < 0.001
Alcohol intake (%) 62.6 14.7 < 0.001
Exercise (%) 32.8 27.7 < 0.001
MS (Y/N) (No., %) 176/650 (21.3/78.7) 338/717 (31.9/68.0) < 0.001
SBP (mmHg) 127.2 ± 17.4 130.1 ± 18.8 < 0.001
DBP (mmHg)   78.8 ± 11.6   78.1 ± 10.7 0.148
FBS (mg/dL) 104.8 ± 28.1 103.9 ± 25.4 0.487
T-Chol (mg/dL) 192.9 ± 36.6 205.8 ± 38.3 < 0.001
TG (mg/dL) 145.1 ± 97.2 139.7 ± 94.9 0.216
HDL-C (mg/dL)   51.9 ± 13.9   55.0 ± 13.8 < 0.001
Cortisol (µg/dL) 13.8 ± 4.6 11.8 ± 4.8 < 0.001
Insulin (µIU/mL)   7.0 ± 4.2   7.3 ± 4.8 0.460
HOMA-IR   1.89 ± 1.57   1.91 ± 1.34 0.897
Values are mean ± SD unless otherwise indicated. BMI, body mass index; SES, so-
cioeconomic status; MS, metabolic syndrome; SBP, systolic blood pressure; DBP, dia-
stolic blood pressure; FBS, fasting blood sugar; T-Chol, total cholesterol; TG, triglyc-
eride; HDL-C, high density lipoprotein cholesterol; HOMA-IR, homeostasis model as-
sessment of insulin resistance. Gender difference of continuous variables were com-
pared using t-test, categorical variables were compared by chi-squared test.Park SB, et al.  •  Cortisol and Metabolic Syndrome in Koreans
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Correlations between cortisol and metabolic syndrome
Regression analysis of cortisol to CVD risk factors while control-
ling for BMI and age are presented in Table 2. Results showed 
that there were significant associations between cortisol and 
SBP, DBP, fasting glucose and total cholesterol in men, and be-
tween cortisol and SBP, fasting glucose and total cholesterol in 
women. Multiple regression analysis showed that after addition-
al adjustment for age, BMI, SES, smoking, alcohol consumption 
and daily activity, higher cortisol levels remained associated with 
higher fasting glucose concentrations in both men (P < 0.001) and 
women (P < 0.002). Cortisol was also significantly associated to 
SBP in both women and men (P = 0.03 and 0.05 respectively). 
The association of cortisol with DBP was significant in men (P = 
0.04), but not in women (P = 0.43). Cortisol tended to be associ-
ated with higher total cholesterol in both men and women (P = 
0.06). The association of cortisol to triglycerides, HDL and WC 
was not significant in either men or women after the additional 
adjustments. 
  To test whether BMI moderated the effect of cortisol on CVD 
risk factors and metabolic syndrome, the interaction term BMI 
× cortisol was calculated and added to the model. However, these 
analyses did not show any significant moderating effect of BMI 
on any of the outcomes (P > 0.10).
Correlations between cortisol, insulin and HOMA
Insulin and HOMA measures were only available in a subset of 
the study participants (n = 633). The mean insulin level was 7.3 
± 4.7 μIU/mL for men (n = 262) and 7.0 ± 4.2 μIU/mL for women 
(n = 371) respectively. In this group, higher levels of cortisol to 
be associated with reduced insulin secretion (Table 3). The as-
sociations of cortisol to insulin and HOMA were not significant 
(P = 0.18 and P = 0.87 respectively), adjusting for age and BMI.
Logistic regression in the prediction of metabolic 
syndrome 
There was an increased risk for the metabolic syndrome associat-
ed with higher cortisol levels in both men (P = 0.000) and women 
(P = 0.040) while adjusting for age and BMI (Table 4). This effect 
remained significant in the men after further adjustments for 
SES, smoking, alcohol drinking, daily activity (P < 0.001), while it 
became non-significant in the women (P = 0.13).
DISCUSSION
Results from the present study suggest that higher levels of fast-
ing cortisol are associated with several CVD risk factors in Ko-
rean men and women, independent of overall adiposity level as 
measured by BMI. Our study also showed that the risk for the 
metabolic syndrome was greater in individuals with high corti-
sol levels after adjusting for age and BMI. This finding is consis-
tent with previous research showing that individuals with met-
Table 2. Regression analysis of serum cortisol to CVD risk factors controlling for age and BMI in men and women
Gender CVD risk factors  B SE β P values
Men WC (cm)
SBP (mmHg)
DBP (mmHg)
FBS (mg/dL)
T-Chol (mg/dL)
TG (mg/dL)
HDL-C (mg/dL)
0.068
0.022
0.036
0.020
0.012
0.002
0.007
0.036
0.009
0.014
0.006
0.004
0.045
0.012
0.133
0.085
0.092
0.124
0.096
0.046
0.022
0.059
0.017
0.009
< 0.001
0.006
0.206
0.537
Women WC (cm)
SBP (mmHg)
DBP (mmHg)
FBS (mg/dL)
T-Chol (mg/dL)
TG (mg/dL)
HDL-C (mg/dL)
0.021
0.021
0.021
0.024
0.011
0.001
-0.020
0.027
0.008
0.014
0.006
0.004
0.002
0.011
0.037
0.082
0.046
0.128
0.084
0.026
-0.058
0.439
0.010
0.142
< 0.001
0.007
0.399
0.063
WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBS, fasting blood sugar; T-Chol, total cholesterol; TG, triglycerides; HDL-C, high density 
lipoprotein cholesterol.
Table 3. Correlation between cortisol, insulin and HOMA-IR
Predictor variables B SE P values
Insulin
Age
BMI
-0.089
-0.065
-0.030
-0.106
0.044
0.047
0.017
0.066
0.042*
0.171
†
0.072
0.108
HOMA-IR
Age
BMI
-0.104
-0.023
-0.030 
-0.136
0.132
0.138
0.017 
0.064
0.429*
0.867
†
0.074 
0.034
*Crude; 
†Controlled for age and BMI. HOMA-IR, homeostasis model assessment of in-
sulin resistance; BMI, body mass index.
Table 4. Logistic regression in the prediction of metabolic syndrome 
Gender Predictor variables B SE P values
Men Cortisol
Age
BMI
1.084
1.025
1.403
0.021
0.009
0.036
< 0.001
0.006
< 0.001
Women Cortisol
Age
BMI
1.031
1.009
1.277
0.015
0.007
0.808
0.040
0.224 
< 0.001
BMI, body mass index.Park SB, et al.  •  Cortisol and Metabolic Syndrome in Koreans
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abolic syndrome have increased cortisol secretion (19, 20) and 
cortisol metabolite levels (21). Further adjustment for SES sta-
tus, smoking, alcohol drinking and daily activity reduced this 
effect in women, but not in the men. 
  We found a negative association of cortisol to BMI and WC in 
the women, and no association between cortisol and BMI or WC 
in the men. These findings were consistent with previous stud-
ies showing that cortisol levels were not elevated in obese as 
compared to normal weight individuals (8, 9), and also in agree-
ment with the study suggesting a diminished stimulability of the 
HPA axis in obese individuals (22). Cortisol is released from the 
subcutaneous adipose tissue by 11beta-HSD1 in humans, and 
increased enzyme expression in obesity is likely to increase local 
glucocorticoid signaling and contribute to whole-body cortisol 
regeneration (23). However, because the previous findings were 
not entirely consistent, it is still not clear whether the enzymatic 
overactivity is a cause or a result of obesity. In addition, our study 
is using a cross sectional design, and can therefore not assess 
whether cortisol levels actually contribute to weight gain over 
time. Hence, the present study can not test whether hypercorti-
solemia favors accumulation of visceral fat as initially suggested 
by Bjorntorp (4) and a recent review (24).  
  The present study showed that cortsiol levels were associated 
to fasting glucose levels in both men and women, even after con-
trolling for age and BMI. This is in line with the notion that glu-
cocorticoids stimulate hepatic gluconeogenesis, leading to in-
creased fasting glucose (25). In addition, glucocorticoids inhibit 
insulin actions on skeletal muscle and potentiate actions on ad-
ipose tissue, promoting the development of the metabolic syn-
drome (26). Cortisol counteracts the insulin activation of glyco-
gen synthesis in muscle, the insulin inhibition of hepatic glucose 
production and the insulin inhibition of lipolysis in adipose tis-
sue, leading to systemic insulin resistance (27). Unfortunately, 
insulin was only available in a subsample of the present study 
participants. Our observation is somewhat consistent with in 
vivo and in vitro experiments showing that glucocorticoids reg-
ulate insulin secretion (28). 
  This differs from previous observations showing a synergistic 
effect of cortisol and adiposity on CVD risk factors. For example, 
studies have shown that the correlation between cortisol and 
systolic blood pressure is most marked in obese subjects (29). 
Although the mechanism of this interaction is unclear, a recent 
study suggests that glucocorticoid action may be increased in 
skeletal muscle, an important insulin target tissue, in obese in-
dividuals (30). 
  Our study population consisted of patients who visited a Uni-
versity Hospital, which may limit the generalizability of our find-
ings. Second, because we employed a cross-sectional design, it 
is not possible to determine whether cortisol was causally relat-
ed to the development of the metabolic syndrome. Longitudi-
nal studies could assess whether circulating cortisol concentra-
tions increases the risk of developing of the metabolic syndrome. 
Further research into the mechanisms behind these observa-
tions may lead to new therapeutic approaches to reduce the 
prevalence of diabetes and metabolic syndrome.
  In summary, this study demonstrates that plasma cortisol 
concentration adds to the effect of adiposity on metabolic out-
comes and suggests a relationship between HPA activity, as in-
dicated by increased fasting cortisol concentration, and increased 
CVD risk independent of adiposity in Korean individuals.
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